“The evidence would suggest that perhaps we need to investigate this pathway and perhaps this drug in both Parkinson’s, ...
Dementia is the umbrella term for all kinds of conditions associated with memory loss of which Alzheimer’s disease is the ...
CervoMed (CRVO) will deliver an oral presentation providing detailed safety and efficacy results from its completed RewinD-LB Phase 2b clinical ...
About 7 million Americans live with chronic neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral ...
Medpage Today on MSN12d
Leukemia Drug Shows Promise in Dementia With Lewy Bodies"We're looking at repositioning or repurposing tyrosine kinase inhibitors for neurodegenerative diseases, including Lewy body ...
ComingSoon on MSN14d
The Penguin: What is Lewy Body Dementia? Francis Cobb’s Diagnosis ExplainedThe Penguin recently aired its sixth episode. The episode was filled with interesting twists and turns, leaving viewers on ...
Topline data from the RewinD-LB Phase 2b study on track for December 2024 Detailed safety and efficacy data from RewinD-LB Phase 2b study to be featured in an oral presentation at the ILBDC conference ...
Nilotinib (Tasigna) — a drug for myeloid leukemia — improved biomarkers and cognitive outcomes in study participants with dementia with Lewy bodies, a new study finds.
"We're looking at repositioning or repurposing tyrosine kinase inhibitors for neurodegenerative diseases, including Lewy body dementia," Turner said. "Due to its promotion of autophagy and perhaps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback